We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...
The parent company of Truth Social said it had applied for trademarks for investment products that would allow supporters to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback